Cortactin Tyrosine Phosphorylation Promotes Its Deacetylation and Inhibits Cell Spreading by Meiler, Eugenia et al.
Cortactin Tyrosine Phosphorylation Promotes Its
Deacetylation and Inhibits Cell Spreading
Eugenia Meiler, Elvira Nieto-Pelegrı ´n, Narcisa Martinez-Quiles*
Departamento de Microbiologı ´a II, Facultad de Farmacia, Universidad Complutense de Madrid, Madrid, Spain
Abstract
Background: Cortactin is a classical Src kinase substrate that participates in actin cytoskeletal dynamics by activating the
Arp2/3 complex and interacting with other regulatory proteins, including FAK. Cortactin has various domains that may
contribute to the assembly of different protein platforms to achieve process specificity. Though the protein is known to be
regulated by post-translational modifications such as phosphorylation and acetylation, how tyrosine phosphorylation
regulates cortactin activity is poorly understood. Since the basal level of tyrosine phosphorylation is low, this question must
be studied using stimulated cell cultures, which are physiologically relevant but unreliable and difficult to work with. In fact,
their unreliability may be the cause of some contradictory findings about the dynamics of tyrosine phosphorylation of
cortactin in different processes.
Methodology/Principal Findings: In the present study, we try to overcome these problems by using a Functional
Interaction Trap (FIT) system, which involves cotransfecting cells with a kinase (Src) and a target protein (cortactin), both of
which are fused to complementary leucine-zipper domains. The FIT system allowed us to control precisely the tyrosine
phosphorylation of cortactin and explore its relationship with cortactin acetylation.
Conclusions/Significance: Using this system, we provide definitive evidence that a competition exists between acetylation
and tyrosine phosphorylation of cortactin and that phosphorylation inhibits cell spreading. We confirmed the results from
the FIT system by examining endogenous cortactin in different cell types. Furthermore, we demonstrate that cell spreading
promotes the association of cortactin and FAK and that tyrosine phosphorylation of cortactin disrupts this interaction,
which may explain how it inhibits cell spreading.
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Introduction
The actin cytoskeleton remodels to accomplish many cellular
processes and therefore undergoes significant changes during cell
migration, adhesion, endocytosis and bacterial invasion [1]. The
cortactin protein has emerged as an important node in the
network regulating the actin cytoskeleton during numerous
biological processes [2,3]. It was originally described as a substrate
of Src kinase located primarily at the cell cortex [4]. Almost
simultaneously, cortactin was cloned as the product of the CTTN
gene (formerly EMS1), located in chromosomal region 11q13,
which is frequently amplified in different human carcinomas [5].
Today, cortactin is considered an oncoprotein and a bona fide
invadopodial marker [6].
Cortactin is a modular protein that contains an N-terminal
acidic (NTA) domain with a 20DDW22 motif that directly binds
and activates the Arp2/3 complex. The NTA domain is followed
by six and a half amino acid ‘repeats’ that bind to F-actin and
define the actin-binding region (ABR) [7]. Since cortactin only
weakly activates the Arp2/3 complex in vitro [8], it is unclear
whether cortactin requires post-translational modifications to be
fully active. The ABR is followed by a helical, proline-rich region,
followed in turn by a C-terminal Src homology (SH3) domain.
Cortactin binds several proteins through its SH3 domain, such as
WIP [9] and neural Wiskott-Aldrich syndrome protein (N-WASP)
[10,11].
Cortactin regulation is very complex [12]. Although tradition-
ally studied as a substrate of Src family kinases (SFKs) [4], it can
also be phosphorylated by other tyrosine kinases such as Fer [13]
and Abl/Arg [14]. The effects of tyrosine phosphorylation on
cortactin structure and function remain largely unknown. This
phosphorylation was shown to decrease cortactin binding to F-
actin [15], and this binding is required for cortactin activation of
the Arp2/3 complex [16]. This phosphorylation is also required
for inducing bone metastasis of breast cancer cells in nude mice
[17], and it appears to be involved in bacterial invasion of cells,
such as for the adhesion of enteropathogenic Escherichia coli (EPEC)
[18]. Protein phosphatase 1B (PTB-1B) dephosphorylates tyrosine
421 in cortactin [19], suggesting reversible regulation. The data
seem to indicate that tyrosine phosphorylation of cortactin is
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clear. Tyrosine phosphorylation-dephosphorylation of cortactin
may regulate its ability to form complexes with other proteins
[20,21].
Cortactin is also the target of serine-threonine kinases, including
ERK [22] and Pak [23,24]. In fact, phosphoproteomic analysis has
revealed numerous phosphorylation sites, most of which are
serines and threonines [25].
Cortactin promotes actin polimerization through two pathways:
directly, by activating the Arp2/3 complex; and indirectly, when
the SH3 domain binds and activates N-WASP [10]. In vitro,
cortactin binds and activates N-WASP only when phosphorylated
on serines by ERK, whereas phosphorylation by Src at tyrosines
421, 466 and 482 terminates cortactin activation of N-WASP,
which suggests that phosphorylation indeed affects cortactin
structure. Based on studies by our group [10] and others [22],
we proposed a model in which serine/tyrosine phosphorylation
controls the accessibility of the SH3 domain of cortactin [10]. This
model was subsequently named the ‘S-Y Switch’ model [26], and
its most easily testable prediction is that cortactin can be regulated
by a conformational change. The structure of unmodified
cortactin [27] reveals a closed, globular conformation achieved
mainly through interactions between the SH3 domain and ABR
region.
Studies with mutant forms of cortactin have been carried out to
understand the functional consequences of serine and tyrosine
phosphorylation. Indeed it has been proposed that different
cortactin phosphoforms have distinct cellular functions: in this
proposal, tyrosine-phosphocortactin mainly regulates focal adhe-
sion turnover, whereas serine-phosphocortactin controls actin
polimerization [28]. More recently, antibodies specific for
phospho-serine have been used to show that serine phosphoryla-
tion of cortactin is essential for lamellipodial persistence [29].
Adding another layer of complexity to cortactin regulation,
studies have shown that the protein is also regulated by reversible
acetylation. The protein can be acetylated by histone acetyltrans-
ferase p300/CBP-associated factor (PCAF) and deacetylated
mainly by Histone Deacetylase 6 (HDAC6). Acetylated cortactin
has a reduced capacity to bind F-actin [30].
Although numerous studies of cortactin have suggested a
complex network of regulatory post-translational modifications,
they have been unable to indicate definitively how Src-mediated
phosphorylation affects cortactin structure and activity, and how
this phosphorylation relates to other post-translational modifica-
tions. These difficulties may reflect the low basal level of phospho-
tyrosine cortactin in most cell types, which makes cell culture-
based studies of cortactin challenging. Here we attempt to
overcome this problem using the Functional Interaction Trap
(FIT) system [31,32]. The FIT system involves fusing a kinase and
a substrate of interest to complementary leucine zippers;
cotransfection with the two expression vectors allows for specific
and efficient phosphorylation of the substrate.
Methods
Cells, reagents and antibodies (Abs)
The following cell lines were obtained from the American Type
Culture Collection (ATCC): human epithelial HeLa cells; mouse
fibroblasts deficient in Src, Yes, and Fyn kinase (Src
2/2, Yes
2/2,
Fyn
2/2; abbreviated SYF); and SYF fibroblasts rescued for Src
(Src
+/+, Yes
2/2, Fyn
2/2; abbreviated Rsrc). Wild-type (WT) and
HDAC6-deficient MEFs immortalized by p53 gene deletion [33]
were obtained from Dr. Tso-Pang Yao (Department of Pharma-
cology and Cancer Biology, Duke University). Cells were grown in
Iscove’s modified Dulbecco’s medium (IMDM) supplemented with
10% fetal bovine serum (FBS) and antibiotics. The deacetylase
inhibitor Trichostatin A (TSA) from Streptomyces sp was purchased
from Sigma. The selective Src-family kinase inhibitor PP2 was
purchased from Calbiochem.
The following commercial Abs were purchased from Millipore:
mouse cortactin 4F11 MoAb; mouse Src GD11 MoAb; mouse
myc 4A6 MoAb; Platinum phospho-tyrosine (for WB), which is a
mixture of two generic phosphotyrosine Abs: PY20 and 4G10;
vinculin MoAb; and FAK 2A7 MoAb (for IPs). For immunopre-
cipitations (IPs), we used phosphotyrosine MoAb and for FAK
WB, the Ab from Cell Signaling. Mouse actin C4 MoAb was from
MP Biomedicals, and rabbit cortactin MoAb was from Novus
Biologicals. The rabbit cortactin polyclonal Ab (Applied Biological
Materials) was raised against an unphosphorylated peptide around
tyrosine 466. This Ab recognizes both unphosphorylated and
tyrosine-phosphorylated cortactin. Rabbit phosphocortactin Y466
polyclonal Abs were obtained from Santa Cruz Biotechnology and
from Abcam (data not shown). Myc (A14) Ab was from Santa
Cruz. pY421 cortactin Ab was from Abcam. Rabbit Ab against
acetyl-cortactin was initially obtained from Dr. Edward Seto (H.
Lee Moffitt Cancer Center and Research Institute, Tampa,
Florida) and subsequently from Millipore.
IRDye 800CW-labeled goat rabbit and mouse secondary Abs
(Fisher Scientific) were used to give green signal. IRDye 680CW-
labeled goat rabbit Ab (Fisher Scientific) and Alexa 680-labeled
goat mouse Ab (Invitrogen) were used to give red signal. All
secondary Abs were purchased at a concentration of 1 mg/ml and
used at 1:5,000 dilution.
Constructs
All FIT constructs used, including MycCortactin, were a
generous donation of Dr. Bruce J. Mayer (Connecticut Health
Center, CT, USA). Cortactin with mutations of all three tyrosines
that can be phosphorylated by Src (Y421/466/482F, referred to as
the 3F mutant) was produced using the QuikChange site-directed
mutagenesis kit (Stratagene). Mutations were produced sequen-
tially: first the 421F mutant was generated, and then this was used
as template to mutate Y466 and Y482 (primer sequences available
upon request). After verifying the sequence, the insert was
subcloned into an empty ZipB vector. WT GFP-cortactin and
3F-GFP constructs were previously described [10].
Cell transfection and Western blotting (WB)
For transfection, plasmid DNAs were purified with endotoxin-
free, transfection-grade JetStar 2.0 Midi columns (Genomed) as
per the manufacturer’s instructions. Cell transfections were carried
out using Lipofectamine 2000 (Invitrogen) or Fugene HD
transfection reagent (Roche). Briefly, cells were grown to 60–
75% confluence for Lipofectamine transfections or to 50–60%
confluence for Fugene transfections in 6-well plates using 2 mgo f
the indicated plasmids per well. Transfections were incubated for
approximately 20 h in medium containing 10% FBS but no
antibiotics.
WB was carried out on cells from a single well or, when
necessary, from a 100-mm plate. Cells were washed once with cold
Dulbecco’s phosphate-buffered saline (D-PBS) with calcium and
magnesium (Invitrogen) and scraped into 300 ml2 6 Laemmli
buffer. Samples were homogenized by three passages through a
syringe with a 25-gauge needle and then centrifuged at 21,0006g
for 5 min at 4uC. Samples were resolved by 10% SDS-PAGE and
transferred to nitrocellulose membranes (Amersham) using a
BioRad transfer system. Membranes were blocked for 1 h with
Odyssey blocking buffer and incubated overnight with primary Ab
Acetylation versus Phosphorylation of Cortactin
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washed 4 times for 5 min with PBS containing 0.1% Tween 20,
then incubated for 1 h with the appropriate secondary antibody,
and washed as before. Membranes were scanned with the Odyssey
infrared system (Lycor, Fisher Scientific) using the red (700 nm)
and green (800 nm) channels. When required, membranes were
stripped using Odyssey stripping buffer according to the
manufacturer’s instructions. When significantly different intensities
were observed between the two color signals, we performed
sequential Ab incubations. After stripping membranes, we
incubated them with secondary Ab alone and scanned them to
confirm the efficiency of stripping before incubating them with
another primary Ab.
Quantification of the bands was performed on the scanned
images using the Odyssey Scan band tool. The results were
analyzed by the two-tailed Student’s t test and displayed
graphically using GraphPad Prism software (version 5.0).
Pervanadate treatment
Pervanadate solution was prepared by mixing 1 mM Na3VO4
with 1% H2O2 (both from Sigma), diluting two-fold with IMDM
medium and used for 30 min at 37uC and 5% CO2.
Immunoprecipitation (IP) experiments
Cells were grown on 150-mm plates and transfected as
described above with 20 mg of each plasmid. After transfection
cells were washed once with D-PBS and scraped into 700 ml
modified RIPA buffer [50 mM Tris-HCl (pH 7.4), 150 mM NaCl,
15% glycerol, 2 mM EDTA, 0.1% SDS, 1% Triton X-100, 1 mM
Na3VO4, 10 mM NaF, 1 mM PMSF, protease inhibitor cocktail
(Amersham), phosphatase inhibitor (PhosSTOP, Roche)]. When
indicated, TSA was added to the RIPA buffer at a final
concentration of 400 ng/ml to detect cortactin acetylation [30],
except in the case of lysates from WT or HDAC6-deficient cells.
Magnetic mouse or protein G Dynabeads (30 ml/IP, Invitrogen)
were washed and blocked with PBS containing 0.1% BSA for
10 min, then incubated 1 h with 4 mg Ab per IP. After one wash
with PBS-0.1% BSA, the beads were added to 200–300 ml cell
lysate and incubated with rotation at 4uC for 4 h. The beads were
washed 3 times with the help of a magnet (Invitrogen) and 200 ml
lysis buffer diluted 1:10 in PBS supplemented with TSA, except in
the case of lysates from WT or HDAC6-deficient cells, when TSA
was omitted. The beads were resuspended in 40 ml2 6 Laemmli
buffer and processed for SDS-PAGE or frozen at 280uC until
further analysis.
Pull-down (PD) experiments
GST and the GST-cortactin SH3 domain were produced in
BL21 E. coli, purified and coupled to GSH-beads [10]. The
proteins were added to 200 ml cell lysate and incubated for 3 h
with tumbling at 4uC. Pull-downs were washed twice with 200 ml
lysis buffer diluted 1:10 in PBS.
Immunofluorescence microscopy
Cells were fixed for 20 min at room temperature with 4%
formalin (Sigma) and permeabilized with 0.1% Triton X-100 for
5 min. After three washes with PBS, cells were blocked with 2%
BSA in PBS for 10 min, stained at room temperature (RT) with
the appropriate primary Ab for 1 h, washed 3 times with PBS, and
finally incubated 1 h with secondary Ab. Actin cytoskeleton was
visualized with 1 mg/ml tetramethyl-rhodamine-isothiocyanate
(TRITC)-phalloidin (Sigma) or a 1:25 dilution of Alexa Fluor
350-phalloidin (Invitrogen). The secondary Abs (Invitrogen) were
Alexa Fluor 405-labelled mouse (blue), Alexa Fluor 488-labeled
mouse and -rabbit (green), and Alexa 568-labeled rabbit (red).
Counting was done using a Nikon Eclipse TE 200-U
fluorescence microscope equipped with a Hamamatsu camera.
Images were processed with Adobe Photoshop. Confocal micros-
copy was performed at the Parque Cientı ´fico de Madrid
microscopy facility with a Leica Confocal SP2/DMEIR2, using
Leica software (version 2.61).
Spreading experiments
Cells were transfected for 20 h, trypsinized and washed once
with trypsin inhibitor at 0.5 mg/ml (Sigma). For immunofluores-
cence studies, 2.5610
5 cells per time point were replated on 4
coverslips previously treated with 30 mg/ml fibronectin (Calbio-
chem) in each well of a 6-well plate. After fixation they were
processed for immunofluorescence. For FAK pull-down and IP
experiments, transfections were carried out in 150-mm plates, and
cultures were trypsinized 20 h later. For each condition, 2.5610
6
trypsinized cells were kept in suspension or replated on
fibronectin-treated 100-mm plates.
Results
Efficient tyrosine phosphorylation of cortactin by Src in
cells transfected with the FIT system
To specifically phosphorylate cortactin in cells with Src kinase,
we used the FIT system (Fig. 1, schematic cartoon). HA-tagged Src
kinase lacking the SH2 and SH3 domains was expressed with a C-
terminal leucine zipper from the Leucine-ZipA vector (ZipAHA-
DSrc), while myc-tagged cortactin was expressed with an N-
terminal leucine zipper from the Leucine-ZipB vector (ZipBMyc-
Cortactin) (Fig. 1, lane 5). As controls, we transfected different
vector combinations (Fig. 1A) and left cells untransfected (lane 9).
We performed these transfections in SYF fibroblasts, which lack
the three SFKs (Src, Yes, Fyn) predominant for that cell type [34].
We also performed these transfections in control cells reconstituted
with Src (Rsrc cells).
WB of cell lysates was carried out using the Odyssey two-color
infrared scanning system. Src targets tyrosines 421, 466, and 482
of mouse cortactin [35]. We observed strong tyrosine phosphor-
ylation of transfected cortactin using a phospho-specific Ab against
tyrosine 466 (pY466 Ab). Simultaneously we detected both
endogenous cortactin, migrating at 80–85 kDa, and transfected
cortactin using the 4F11 mouse MoAb (Fig. 1A). We next merged
the images to show that the phosphorylated band superimposes on
the transfected cortactin band, and that the mobility of both bands
was slightly lower than that of unphosphorylated cortactin. Actin
was detected as a loading control. Similar results were obtained
with a different cortactin pY466 Ab (data not shown). Using the
FIT system, we found no appreciable differences in the levels of
cortactin phosphorylation between SYF and Rsrc cells.
To analyze how efficiently the FIT system generated phosphor-
ylated cortactin, we transfected truncated Src kinase and cortactin
without the ZipA or ZipB domains, respectively (Fig. 1A, lines 4
and 8). The results show that cotransfection of Src and cortactin
increases tyrosine phosphorylation of cortactin, and that the
phosphorylation level is much higher when the leucine zipper
domains are used, in agreement with previous studies using the
FIT system [32].
We also analyzed the phosphorylation of position 421 using a
pY421 Ab (Fig. 1B). The results in Fig. 1A and 1B indicate that the
FIT system allows efficient phosphorylation of cortactin on
tyrosines 421 and 466. In subsequent experiments, we used the
pY466 Ab because it gave a stronger signal than the pY421 Ab.
Acetylation versus Phosphorylation of Cortactin
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with mouse myc 4A6 MoAb and rabbit cortactin MoAb. Fig. S1A
shows that transfected cortactin is recognized equally well by both
Abs. This was further confirmed by the superposition of bands
generated with the 4F11 Ab and the rabbit cortactin MoAb (data
not shown). These results show that endogenous and transfected
ZipBMyc-Cortactin can be detected by either MoAb, though the
signal intensity was greater with the rabbit MoAb.
As a control for the transfections we blotted with antibodies
against the HA tag to detect both HA-DSrc (Fig. S1B, lanes 1, 4
and 8) and ZipAHA-DSrc (lanes 2 and 5). We confirmed the
genotype of the SYF and Rsrc cells by blotting with Src MoAb
GD11 (Fig. S1B).
Substrate specificity of Src kinase in the FIT system
To determine whether cortactin is the primary Src substrate
phosphorylated in cells transfected with the FIT system, we
analyzed the cell lysates by WB using mouse MoAbs against
generic phospho-tyrosine (Platinum Ab: 4G10+PY20) (Fig. S2).
The same membrane was also incubated with rabbit cortactin
MoAb. We observed a strong phospho-tyrosine band that
comigrated with transfected cortactin (lane 5, asterisk). When
Src kinase is activated, it is phosphorylated on tyrosines, which
explains why we observed in lanes 2 and 5 a band of slightly higher
molecular weight than actin that corresponds to ZipAHA-DSrc.
Similarly, we observed Src kinase in the reconstituted Rsrc cells.
These results demonstrate that the major phospho-protein in our
lysates is transfected ZipBMyc-Cortactin that is tyrosine-phos-
phorylated by ZipAHA-DSrc (lane 5, asterisk).
As a second control of phosphorylation specificity, we analyzed
whether the Src substrate paxillin [36] is phosphorylated by our
transfected Src kinase. We performed WB using a phospho-
paxillin (p-paxillin) Ab. In Fig. 2A we show the most relevant
transfections (lanes 4 and 5) from two FIT experiments (FIT8 and
FIT9), after blotting with p-paxillin Ab. As an internal control, we
treated both cell types with pervanadate, a generic phosphatase
inhibitor that induced a strong signal for p-paxillin. While
untreated cell lysates did not show detectable paxillin phosphor-
ylation, lysates of treated cells did. Thus we can conclude that our
transfected cells express a basal level of phospho-paxillin.
Positional specificity of Src kinase in the FIT system
Src phosphorylates tyrosines 421, 466 and 482 in mouse
cortactin [35]. After detecting cortactin phosphorylation at
positions 421 and 466, we wanted to exclude the possibility of
phosphorylation at other tyrosines. For this purpose we used a
non-phosphorylatable mutant in which the three major residues
targeted by Src kinase were replaced by phenylalanine (3F). We
carried out our experiments in HeLa cells because the experiments
described above showed similar results in SYF and Rsrc cells, and
HeLa cells are easier to handle and widely used.
We cotransfected cells with ZipAHA-DSrc and either ZipBMyc-
Cortactin or ZipBMyc-Cortactin 3F, and performed WB using
Abs against generic phospho-tyrosine and cortactin. Cortactin was
phosphorylated on tyrosines, while the 3F mutant was not (Fig. 2B,
lanes 4 and 5), indicating that cortactin is phosphorylated
specifically on the expected tyrosines.
Relationship between tyrosine phosphorylation and
acetylation of cortactin
Cortactin is acetylated mainly in the cortactin repeat region,
and this modification decreases the ability of cortactin to bind F-
actin [30]. Because cortactin phosphorylation by Src has a similar
effect [15], we wanted to analyze whether a relationship exists
between the two post-translational modifications.
Figure 1. Efficient tyrosine phosphorylation of cortactin by Src in cells using the FIT system. SYF and Rsrc cells were transfected with
different combinations of Src and cortactin FIT fusion vectors (lanes 1–8) or left untransfected (lane 9). Cell lysates were blotted for actin as a loading
control and with different Abs, then blotted with the respective conjugated secondary antibodies and finally visualized with the Odyssey system. The
lysates were blotted with (A) pY466 or (B) with pY421 cortactin Abs. In both cases, we observed a clear specific phosphorylation band (in green)
when ZipA-HA-DSrc and ZipB-MycCortactin were cotransfected (transfection 5), and this band superimposes (asterisks) on the cortactin band
detected with the 4F11 MoAb (in red). Sizes of the molecular weight markers (denoted M) are shown in kDa. A schematic cartoon of the FIT system is
shown.
doi:10.1371/journal.pone.0033662.g001
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acetylation was previously detected in this cell type [30]. Cells
were transfected with empty vectors (Fig. 3, lane 1), with
ZipBMyc-Cortactin plus HA empty vector (lane 2), or with
ZipBMyc-Cortactin together with HA-DSrc (lane 3) or ZipAHA-
DSrc (lane 4). Transfected cells were left untreated or treated with
Trichostatin A (TSA), a deacetylase inhibitor previously used to
prevent deacetylation of cortactin [30]. WB experiments were
performed to confirm tyrosine phosphorylation of cortactin using
the pY466 Ab (Fig. S3A). As expected, cortactin was strongly
phosphorylated when ZipBMyc-Cortactin was cotransfected with
ZipAHA-DSrc (lane 4), and the phosphorylation signal was much
lower when ZipBMyc-Cortactin was cotransfected with HA-DSrc
(lane 3).
To analyze whether phospho-cortactin was simultaneously
acetylated, we performed IPs of transfected cortactin using a
myc MoAb, followed by WB with an Ab specific for acetyl-
cortactin (Fig. 3A). The results show that cortactin was efficiently
immunoprecipitated in all samples, while it was undetectable in
the isotype control IP (Fig. 3A, right panels). Acetyl-cortactin was
nearly undetectable in the sample in which cortactin was strongly
phosphorylated (lane 4), whereas it was clearly detectable when
cortactin was not phosphorylated (lane 2). Treating cells with TSA
increased the apparent level of acetyl-cortactin, suggesting that it
prevents the deacetylation of cortactin as previously described
[30].
In addition to checking cortactin phosphorylation in the lysates
used to perform the IPs (Fig. S3A), we wanted to check the
phosphorylation status in the immunoprecipitates (Fig. 3A). The
membrane was gently stripped until the green acetyl signal was lost
and then reprobed with pY466 Ab and myc MoAb. As expected,
the myc immunoprecipitates showed cortactin phosphorylation
mainly when ZipAHA-DSrc and ZipBMyc-Cortactin were cotrans-
fected(lane4).Whentransfectedalone,ZipBMyc-Cortactinwasnot
detectably phosphorylated, yet it presented a strong acetylation
signal (Fig. 3A, lane 2). The results suggest that acetylation and
phosphorylation of cortactin occur antagonistically.
To confirm these results separate IPs were carried out in parallel
with myc MoAb and generic phospho-tyrosine MoAb (pTyr
MoAb) (Fig. 3B). To simplify the experiment we used only TSA-
treated cells and the most relevant vector combinations: empty
vectors (lane 1), empty HA-vector and ZypBMyc-Cortactin (lane
2), and ZipAHA-DSrc and ZipBMyc-Cortactin (lane 3). IP with
pTyr MoAb was performed only in the cotransfection of ZipAHA-
DSrc and ZipBMyc-Cortactin, where cortactin should be
phosphorylated. Again, we observed that tyrosine-phosphorylated
cortactin was not acetylated and vice versa. Thus no signal for
acetylation was detected in the phospho-tyrosine IP, which pulled
down only tyrosine-phosphorylated cortactin. In contrast, a very
faint acetylation signal was detected in the myc IP, which pulled
down primarily phosphorylated cortactin but also a small fraction
of unphosphorylated protein. We found a statistically significant
difference in acetylation signal between unphosphorylated cortac-
tin (transfection 2) and tyrosine-phosphorylated protein (transfec-
tion 3; Fig. 3B).
To verify these results with tyrosine-phosphocortactin by a
different approach we performed IPs with the pY466 cortactin Ab
(Fig. S3B) using the same vector combinations as above (Fig. 3B).
The immunoprecipitates and lysates were blotted with cortactin
4F11 MoAb, which detects both transfected and endogenous
cortactin in lysates. Tyrosine-phosphorylated cortactin was
efficiently immunoprecipitated when ZipAHA-DSrc and ZipB-
Myc-Cortactin were cotransfected (lane 3). WB with acetyl-
cortactin Ab revealed that pY466 immunoprecipitates did not
contain acetylated cortactin, which is consistent with previous
results (Fig. 3A, B). These results indicate that the two
modifications did not occur simultaneously, suggesting that a
competition exists between phosphorylation and acetylation of
cortactin.
To exclude any non-specific effects due to the fusion tag and to
further characterize how these two post-translational modifications
relate to each other, we performed transfections using GFP-tagged
cortactin constructs (Fig. 4). We transfected HeLa cells with empty
vector and a vector encoding GFP-WT cortactin or GFP-3F
cortactin, and we blotted the lysates with acetyl-cortactin Ab. We
observed that WT and GFP-3F cortactin were acetylated (Fig. 4A)
and found no statistically significant difference in acetylation level
between the two constructs (data not shown). This indicates that
Figure 2. Specificity of tyrosine phosphorylation in the FIT
system. (A) Detection of the phosphorylation status of paxillin,
another Src kinase substrate. SYF and Rsrc cells were transfected with
FIT fusion vectors and the most relevant lysates (4 and 5) from two
different experiments (FIT 8 and 9) were analyzed by WB with a rabbit
Ab against phospho-paxillin (in green) and with a MoAb against actin
(in red). As controls, cells were left untreated or treated with
pervanadate (PV), a potent phosphatase inhibitor that induces the
phosphorylation of paxillin. Rsrc cells showed a higher basal level of
phospho-paxillin than did SYF cells, though in both cell lines, this basal
level was enhanced by treatment with PV. The FIT system did not
increase the basal level of phospho-paxillin. (B) Tyrosine phosphoryla-
tion of cortactin occurs on the expected tyrosines (Y421, Y466 and
Y482). HeLa cell lysates were transfected with ZipA-HA-DSrc and ZipB-
MycCortactin (lane 4) or with ZipA-HA-DSrc and ZipB-MycCortactin with
the triple mutation Y421/466/482F (3F) (lane 5). Several control
cotransfections were done (lanes 1–3). WB with generic pTyr MoAb
demonstrated that only ZipB-Myc WT cortactin, and not the 3F mutant,
was phosphorylated (in green). Cortactin was detected with a rabbit
MoAb (in red). Actin is shown as a loading control.
doi:10.1371/journal.pone.0033662.g002
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required for cortactin acetylation.
We next examined the effects of pervanadate (PV) and TSA on
GFP-cortactin; these compounds induce phosphorylation and
acetylation, respectively (Fig. 4B). Lysates of cells transfected with
GFP-cortactin were left untreated or treated with PV or TSA, and
subjected to WB with the acetyl-cortactin Ab first, followed by
gentle stripping and then reprobing with the pY466 cortactin Ab.
As a transfection control, lysates were also blotted with GFP
MoAb. Treating lysates with TSA increased the amount of acetyl-
cortactin over basal levels. However, we cannot determine
whether it simultaneously decreased the level of phospho-cortactin
because the basal level of the phospho-protein is undetectable. In
contrast, PV strongly induced tyrosine phosphorylation of
cortactin, and this was accompanied by a decrease in the level
of acetyl-cortactin, such that the ratio of the two forms of cortactin
differed significantly from basal conditions (Fig. 4B). These results
indicate that induction of tyrosine phosphorylation of cortactin
decreases its acetylation.
Analysis of the acetylation and phosphorylation status of
endogenous cortactin
The experiments described so far established that acetylation
and phosphorylation of transfected cortactin are mutually
exclusive events. We next analyzed whether the same relationship
holds for endogenous cortactin (Figs. 5, 6). First we performed
experiments in WT and HDAC6-deficient mouse embryonic
fibroblasts (MEFs), because HDAC6 is the major cortactin
deacetylase in cells [30]. IPs using 4F11 MoAb were blotted with
acetyl-cortactin Ab, then the membranes were stripped and
blotted with pY466 Ab (Fig. 5A). IPs from HDAC6-deficient cell
lysates using 4F11 MoAb showed a significantly higher basal level
of acetylated cortactin than did IPs from WT cell lysates. In
addition, the ratio of the acetyl:pY466 signals was significantly
higher in the HDAC6-deficient cells. These results indicate that
the lack of HDAC6 deacetylase significantly increases the
acetyl:pY466 cortactin ratio and that HDAC6-deficient cells are
a valuable reagent to characterize how acetylation and tyrosine
phosphorylation of cortactin relate to each other. Consequently,
we performed cortactin IPs using the acetyl-cortactin Ab and
blotted them with pY466 Ab and 4F11 MoAb. No signal was
detected by pY466 Ab in the immunoprecipitates in which
cortactin was detectable with the 4F11 MoAb (Fig. 5B). To
confirm this result, acetyl-cortactin immunoprecipitates were
analyzed using generic pTyr mouse MoAb or cortactin rabbit
MoAb on separate membranes. Similar results were obtained (Fig.
S4). We confirmed the HDAC6-deficient phenotype of the MEFs
by WB with HDAC6 Ab (Fig. 5C). These results show that
Figure 3. Analysis of acetylation and tyrosine phosphorylation of transfected cortactin. (A) Lysates from various transfection
combinations (lanes 1–4), treated or not with the deacetylase inhibitor Trichostatin A (TSA), were used to perform IPs using a myc MoAb that were
examined by WB first with acetyl-cortactin Ab (in green) and second with myc MoAb (in red). The merge of both images is shown. After the
membrane was gently stripped to remove the acetyl signal, it was blotted with pY466 Ab. The isotype control IP (Ctrl.) is also shown. (B) TSA-treated
cell lysates from various transfection combinations (lanes 1–3) were subjected to parallel IP experiments with the myc MoAb and the generic pTyr
MoAb. The IPs were blotted first with acetyl-cortactin Ab, and second with the myc MoAb; then the membranes were stripped and reprobed with
pY466 Ab and myc MoAb. The asterisks denote non-specific bands. Quantification of the signals from cortactin immunoprecipitates showed a
statistically significant inverse relationship between acetylation and tyrosine phosphorylation signals. a.u.: arbitrary units. *, p,0.05; **, p,0.01.
doi:10.1371/journal.pone.0033662.g003
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WT or HDAC6-deficient cells.
We next examined cortactin acetylation in SYF and Rsrc
MEFs, because they represent cell types with different levels of
tyrosine-phosphorylated cortactin (Fig. 6). Separate IPs were
carried out in parallel using 4F11 and pTyr MoAb and blotted first
with rabbit acetyl-cortactin Ab. Then the blot was stripped and
reprobed with pY466 cortactin Ab. To detect immunoprecipitated
cortactin the membrane was stripped again and reprobed with a
cortactin Ab (Fig. 6A). We detected acetyl-cortactin in immuno-
precipitates prepared from SYF and Rsrc cell lysates using
cortactin 4F11 MoAb. Parallel IPs performed with the pTyr
MoAb showed that endogenous tyrosine-phosphorylated cortactin
was present only in Rsrc cell lysates, as expected. Furthermore,
this cortactin fraction was not acetylated (see asterisks, Fig. 6A).
We quantified three independent experiments and found that
4F11 immunoprecipitates from SYF and Rsrc cells differed
significantly in the ratio of acetyl:pY466 cortactin (Fig. 6A). These
results indicate that when most of the immunoprecipitated
cortactin is tyrosine-phosphorylated, then is not concomitantly
acetylated.
To confirm these results, we performed IPs from SYF and Rsrc
cell lysates with pY466 cortactin Ab (Fig. 6B). The immunopre-
cipitates were blotted with acetyl-cortactin Ab and cortactin 4F11
MoAb, gently stripped, and then reprobed with pY466 cortactin
antibody (Fig. 6B). As detected in Fig. 6A, tyrosine-phosphorylated
cortactin was immunoprecipitated only from Rsrc cell lysates.
More importantly, cortactin phosphorylated on Y466 was not
acetylated (Fig. 6B). Again as detected in Fig. 6A, when cortactin
was immunoprecipitated with a generic antibody such as 4F11
MoAb, the immunoprecipitates contained both acetylated and
tyrosine-phosphorylated cortactin. On the contrary, when cortac-
tin was immunoprecipitated with a generic phospho-tyrosine
MoAb or a specific pY466-cortactin Ab, only tyrosine-phosphor-
ylated cortactin was immunoprecipitated and it was not acetylated.
Together these results demonstrate that the majority of endoge-
nous cortactin is acetylated or tyrosine-phosphorylated, consistent
with the results obtained with transfected cortactin.
Analysis of cortactin acetylation and tyrosine
phosphorylation during cell spreading
We performed FIT transfections of SYF and Rsrc cells to
visualize the location of nonphosphorylated cortactin (transfection
2) and phosphorylated protein (transfection 3). As negative
controls, we left cells untransfected and we transfected them with
empty vectors (Fig. S5 and data not shown). We visualized cell
morphology with TRICT-phalloidin (Fig. S5). We also examined
high-magnification images to study cell morphology in detail. We
detected cortactin expression using myc MoAb and cortactin
phosphorylation using pY466 Ab. As in the IPs (Fig. 6), the level of
endogenous cortactin that was tyrosine-phosphorylated in SYF
cells under our experimental conditions was nearly undetectable;
the level of phosphorylation was similar to that observed in cells
transfected only with cortactin (transfection 2, TF2). Cotransfec-
tion of cortactin and Src kinase in the FIT system (TF3) increased
the level of phospho-cortactin in cells, and this level was easier to
observe in SYF cells because of their null background level. In SYF
cells, cortactin localized to the cell periphery and around the
nucleus, as previously described for endogenous cortactin [7].
In contrast to SYF cells, untransfected Rsrc cells showed, as
expected, a detectable level of tyrosine-phosphorylated cortactin
(data not shown), as did Rsrc cells transfected in the TF2
experiment. Some cells showed clusters of actin and phospho-
cortactin (arrows, Fig. S5). Images from TF3 showed that Rsrc
cells were somewhat more retracted and detached than their TF2
counterparts. These results demonstrate that transfected and
endogenous tyrosine-phosphorylated cortactin show similar local-
ization, and suggest a role for phospho-cortactin in cell adhesion.
To test this hypothesis, we examined the spreading of
transfected SYF and Rsrc cells on fibronectin (Fig. 7). Fig. 7A
shows representative spread and non-spread SYF and Rsrc cells
Figure 4. Analysis of acetylation and tyrosine phosphorylation of transfected GFP-cortactin. (A) Tyrosine phosphorylation of cortactin is
not required for acetylation of the protein. HeLa cells were transfected with vectors encoding GFP fused with WT cortactin or the Y421/466/482F non-
phosphorylatable cortactin mutant (3F). Lysates were blotted with acetyl-cortactin Ab and GFP MoAb. Transfected cortactin was acetylated and no
statistically significant difference was found in acetylation level between WT and 3F transfectants (data not shown). (B) Tyrosine phosphorylation of
cortactin decreases acetylation of the protein. HeLa cells were transfected with a vector encoding GFP fused with WT cortactin. Transfectants were
left untreated (-) or treated with pervanadate (PV), a generic phosphatase inhibitor, or with Thrichostatin A (TSA), a deacetylase inhibitor. Lysates were
blotted with acetyl-cortactin Ab and with GFP MoAb. After stripping, the membrane was incubated with pY466 cortactin, which was merged with the
GFP cortactin signal. The ratio of acetyl:pY466 cortactin is shown for untreated (-) and PV-treated cells. a.u.: arbitrary units. **, p,0.01.
doi:10.1371/journal.pone.0033662.g004
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or ZipB-MycCortactin and ZipAHA-DSrc (TF3). We counted 100
transfected cells and classified then as spread or non-spread for two
different time points under three transfection conditions [TF1
(empty vectors), TF2 (cortactin) and TF3 (tyrosine-phosphorylated
cortactin)]. In TF3 we counted only transfected cells that also
showed significant phosphorylation signal. Quantification of the
results showed that at 1 h after replating, cells overexpressing
cortactin (TF2) showed significantly more cell spreading than did
TF1 or TF3 cells. More importantly, expression of tyrosine-
phosphorylated cortactin (TF3) significantly inhibited cell spread-
ing compared to TF1 or cortactin-transfected cells (TF2). This
pattern of spreading was also observed at 3 h after replating.
Analysis of cells that did not spread confirmed that cortactin favors
spreading, while tyrosine-phosphorylated cortactin inhibits it.
Indeed, at 6 and 18 h after replating, most Rsrc cells in TF3
were detached (data not shown). Similar results were found in SYF
cells, although the differences among the three transfection
conditions did not reach statistical significance. These results
suggest that cortactin expression favors cell spreading, while
cortactin phosphorylation counteracts this effect (Fig. 7A).
To further understand the role of tyrosine phosphorylation of
cortactin and explore how it relates to cortactin acetylation during
cell spreading, we analyzed the spreading of Rsrc cells on
fibronectin in the presence and absence of PP2, a widely used
Src family kinase inhibitor (Fig. 7B). Untreated cells were plated
and allowed to spread for 1 and 3 h. Cells on a third plate were
allowed to spread for 1 h and then they were cultured for 2 h in
the medium containing 10 mM PP2. Cell lysates were subjected to
IPs with cortactin 4F11 MoAb or isotype control Ab. The
membranes were first blotted with acetyl-cortactin Ab, the acetyl
signal was stripped, and then the membranes were reprobed with
pY466 cortactin Ab and 4F11 cortactin MoAb. We observed that
PP2 treatment nearly abolished cortactin tyrosine phosphorylation
(right panel IPs, Fig. 7B) and increased the intensity of the acetyl-
cortactin signal (left panel IPs). Quantification of three indepen-
dent experiments showed that treatments with PP2 significantly
increased the ratio of acetyl:pY466 cortactin. These results
indicate that inhibition of tyrosine phosphorylation of cortactin
during cell spreading induces cortactin acetylation.
To characterize how cell spreading is altered by tyrosine
phosphorylation of cortactin, we stained focal adhesions using
vinculin as a marker (Fig. 8). We performed FIT transfections of
SYF and Rsrc cells as before and allowed them to spread on FN
for 3 hours (Fig. 8). We visualized focal adhesions by immunoflu-
orescence staining with vinculin MoAb and detected expressed
protein using myc Ab in cells transfected with empty vectors (TF1)
or in cells overexpressing unphosphorylated cortactin (TF2) or
tyrosine-phosphorylated cortactin (TF3). We observed that cells
overexpressing tyrosine-phosphorylated cortactin (TF3) showed
markedly fewer focal adhesions than under the TF1 and TF2
conditions, and these differences were more apparent in Rsrc cells
(Fig. 8) than in SYF cells. Many cells in TF3 had an elongated
morphology, in agreement with previous observations (Fig. 7).
Cell spreading induces the interaction of cortactin with
focal adhesion kinase (FAK), and this interaction is lost
upon tyrosine phosphorylation of cortactin
To understand how tyrosine phosphorylation of cortactin may
affect the formation of focal adhesions, we focused on a recently
described cortactin partner, focal adhesion kinase (FAK) [37],
which plays important roles in focal adhesion dynamics [38].
We examined the spreading of HeLa cells on fibronectin, and in
parallel left them in suspension as a negative control (Fig. 9). Since
Figure 5. Analysis of acetylation and tyrosine phosphorylation of endogenous cortactin in WT and HDAC6-deficient MEFs. (A)
Isotype control (Ctrl.) and 4F11 immunoprecipitates from cell lysates of WT and HDAC6-deficient MEFs (H) were blotted first with acetyl-cortactin Ab
(in green) and second with the 4F11 cortactin MoAb (in red). The merge of both images is shown. After gentle stripping to remove the acetyl signal,
the membrane was blotted with pY466 Ab and 4F11 MoAb. Quantification and statistical analysis of three independent 4F11 immunoprecipitates and
the ratio of acetyl:pY466 cortactin signals are shown. a.u.: arbitrary units. *, p,0.05. (B) Immunoprecipitates obtained with acetyl-cortactin Ab were
blotted with pY466 Ab and 4F11. The phosphorylation signal did not coincide with acetylated cortactin. (C) Blotting of WT and HDAC6-deficient cell
lysates with HDAC6 Ab is shown as a control of cell phenotype.
doi:10.1371/journal.pone.0033662.g005
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while cortactin lacking the SH3 domain does not [37], we
performed pull-down experiments on the lysates using recombi-
nant purified cortactin SH3 domain fused to GST (GST-SH3) or
GST alone as a negative control (Fig. 9A). We found that cortactin
SH3 domain was able to pull down much more FAK from the
lysates of spread cells than from lysates of suspended cells. Similar
results where obtained with Rsrc lysates (data not shown). These
results indicate that focal adhesion formation during cell spreading
induces cortactin-FAK association (Fig. 9B).
To confirm the cortactin-FAK interaction during cell spreading
and to determine whether it is affected by tyrosine phosphoryla-
tion of cortactin, we performed IPs from cell lysates overexpressing
cortactin (TF2) or tyrosine-phosphorylated cortactin (TF3)
(Fig. 9C). We immunoprecipitated FAK using a FAK mouse
MoAb. The immunoprecitates were blotted sequentially, first with
myc Ab and secondly with FAK Ab, and lastly with pY466
cortactin Ab. Interestingly, we observed that FAK immunopre-
cipitated cortactin but not tyrosine-phosphorylated cortactin (see
asterisk, Fig. 9C). This result implies that FAK is associated with
cortactin, but not when it is tyrosine-phosphorylated.
Discussion
Cortactin phosphorylation is predicted to have important
physiological consequences [26] that are not yet fully understood.
Although cortactin is a classical Src kinase substrate, the functional
consequences of its tyrosine phosphorylation remain unclear. The
low basal level of tyrosine-phosphorylated cortactin, and poor
reproducibility of results when stimulating cell cultures with
growth factors such as EGF and PDGF, have made it challenging
to understand how tyrosine phosphorylation regulates cortactin
activity. To avoid these problems, we used the FIT system to study
the effect of Src-mediated phosphorylation of cortactin in cells. In
this system, a leucine zipper motif, consisting of a pair of
complementary amphipathic helices [39], is added to both Src and
its substrate, in this case cortactin.
Src kinase targets tyrosines 421, 466 and 482 of murine
cortactin [35]. Src family kinases (SFKs) are composed of
separable modules that include SH2 and SH3 domains [34].
Different systems have been used to study SFK substrates and
signal transduction pathways. The hemopoietic cell Src kinase
(Hck) was reengineered by substituting the SH2 and SH3 domains
with a PDZ domain to alter the kinase’s substrate specificity [40].
In another study, a temperature-sensitive vSrc mutant was found
to increase tyrosine phosphorylation of cortactin [41]. The FIT
system has been used successfully to force efficient phosphorylation
of desired substrates in cells [31], including Src-mediated
phosphorylation of paxillin, p130Cas and cortactin [32].
In the present study, we set up the FIT system and
simultaneously detected levels of total cortactin and tyrosine-
phosphorylated protein, both transfected and endogenous, using
two commercial Abs against phospho-Y466 and the 4F11 MoAb
(Fig. 1A). Transfected cortactin was also detected using a rabbit
cortactin MoAb and a MoAb to recognize the myc tag on our
cortactin constructs. Western blots were visualized with the
Odyssey scanning system, which allowed unambiguous double
labeling of cortactin and phospho-cortactin. We performed these
experiments in SYF and Rsrc fibroblasts to exclude any
contribution from endogenous Src kinases. When cells were
cotransfected with Src and cortactin, both fused to leucine zipper
interaction motifs, we observed a strong phosphorylation signal at
positions 421 and 466 that superimposed on the transfected
cortactin band (Fig. 1A, B).
We next performed various analyses to determine the
phosphorylation specificity of our FIT system. We determined
that cortactin is the major phosphoprotein in our samples, based
on experiments using two generic phospho-tyrosine MoAbs (Fig.
S2). We also showed that our FIT system is specific to cortactin:
the transfections did not affect the phosphorylation status of
paxillin, a known Src substrate (Fig. 2A). Finally, using the non-
phosphorylatable triple cortactin mutant Y421/466/482F (3F), we
verified that Src-mediated phosphorylation of cortactin occurs at
the expected tyrosines (Fig. 2B).
Like phosphorylation, acetylation regulates numerous cellular
functions. In fact, many proteins related to cytoskeletal dynamics
are regulated by acetylation, such as Arp2/3, tubulin, cofilin and
coronin [42]. Cortactin is regulated by reversible acetylation that
occurs mainly in the ABR of the protein [30], and this acetylation
was recently confirmed by ‘‘acetylome’’ analysis [42]. Acetylation
of lysines in the ABR was shown to reduce binding to F-actin,
which inhibits cell migration [30].
Like cortactin acetylation, Src-mediated phosphorylation of
cortactin decreases its binding to F-actin [15]. This binding is
required to activate the Arp2/3 complex [16]. We hypothesized
that the two modifications are interrelated since they have similar
effects on cortactin function, and we explored this idea in the
present study. Using the FIT system, we overexpressed phosphor-
ylated or unphosphorylated cortactin in cells, immunoprecipitated
the protein, and performed WB experiments with Abs against
Figure 6. Analysis of acetylation and tyrosine phosphorylation
of endogenous cortactin in SYF and Rsrc MEFs. Cell lysates of SYF
and Rsrc MEFs were subjected to IPs using (A) isotype control Ab (Ctrl),
4F11 MoAb and generic phospho-tyrosine (pTyr) MoAb. These IPs were
performed in parallel by probing first with acetyl-cortactin Ab (in
green), after a gentle stripping, with pY466 and at last, the membrane
was stripped and reprobed with cortactin Ab. Statistical analysis of the
ratio of acetyl:pY466 cortactin signals is shown for 4F11 immunopre-
cipitates. a.u.: arbitrary units. **, p,0.01. Asterisks denote evidence that
pTyr immunoprecipitates from Rsrc cell lysates contain phospho-
cortactin but not acetyl-cortactin. (B) IPs with pY466 and isotype
control Abs were probed with acetyl-cortactin Ab and 4F11 cortactin
MoAb, and reprobed, after gentle stripping, with pY466 Ab and 4F11
MoAb.
doi:10.1371/journal.pone.0033662.g006
Acetylation versus Phosphorylation of Cortactin
PLoS ONE | www.plosone.org 9 March 2012 | Volume 7 | Issue 3 | e33662Figure 7. Tyrosine phosphorylation of cortactin affects cell spreading. (A) SYF and Rsrc cells were transfected for 20 h with empty vectors
(not shown), ZipB-MycCortactin and empty vector (TF2), or ZipB-MycCortactin and ZipA-HADSrc (TF3). Cells were then trypsinized, replated on
fibronectin-treated coverslips, and fixed at 1 and 3 h. Pictures were taken in a confocal microscope at 6006 magnification. Immunofluorescence
staining was done using myc MoAb (in green), pY466 cortactin Ab (in red) and Alexa Fluor 350-phalloidin (in blue). For each experimental condition, a
representative image of a non-spread and spread cell is shown. * Denotes that spreading of Rsrc cells is incomplete. Images were merged using Leica
software. Scale bars are shown. A total of 100 transfected cells were quantified and classified into two categories: spread or non-spread. Statistical
analysis from 7 independent experiments at 1 and 3 h after replating Rsrc cells is shown for tranfections TF1 (empty vectors), TF2 (cortactin) and TF3
(phosphorylated cortactin). *, p,0.05; **, p,0.01; ***, p,0.001. (B) Inhibition of cortactin phosphorylation increases its acetylation during cell
spreading. Rsrc cells were replated on fibronectin (FN)-coated coverslips and allowed to spread for 1 or 3 h. A third plate was allowed to spread for
1 h and then treated with PP2 for 2 h. The lysates were subjected to IPs using isotype control (Ctrl.) MoAb or 4F11 MoAb and were blotted first with
acetyl-cortactin Ab and second with anti 4F11 MoAb. After gentle stripping, the membrane was incubated with pY466 cortactin Ab and 4F11 MoAb.
Quantification of the ratio of acetyl:pY466 cortactin signals indicated a significantly higher ratio after PP2 treatment. a.u.: arbitrary units. **, p,0.01.
doi:10.1371/journal.pone.0033662.g007
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results, we performed the IPs using a myc MoAb, and then again
using a generic phospho-tyrosine MoAb (Fig. 3A, B) and pY466
cortactin Ab (Fig. S3). The first set of IPs brought down
phosphorylated and unphosphorylated cortactin, whereas the
second set brought down only phosphorylated cortactin. Blotting
with pY466 Ab detected cortactin phosphorylation mainly in the
sample transfected with Zip-cortactin and Zip-Src. These
experiments show that acetylation and phosphorylation of
cortactin are mutually exclusive: acetylated cortactin is not
phosphorylated and vice versa (Fig. 3). Another major finding of
our study is that when WT cortactin is expressed in transfected
cells, at least some of it is acetylated (Figs. 3 and 4) and therefore
predicted to be inactive [30].
To determine whether the competition observed between
acetylation and phosphorylation of transfected cortactin also holds
for the endogenous protein, we carried out experiments in two cell
types. The first was WT and HDAC6-deficient MEFs. HDAC6 is
the major deacetylase acting on cortactin [30]. As expected, we
found the HDAC6-deficient cells to have a significantly higher
basal level of acetylated cortactin than did WT cells, as previously
described using siRNA techniques [30]. More importantly, we
confirmed in both cell types our finding of a competition between
acetylation and tyrosine phosphorylation. We did this in two types
of IP experiments, one using the 4F11 MoAb and the other using
an Ab against acetyl-cortactin (Fig. 5). In the latter IPs, acetyl-
cortactin did not show detectable tyrosine phosphorylation, as
assessed by either pY466 cortactin Ab or generic pTyr MoAb (Fig.
S4). These two IP experiments were repeated on endogenous
cortactin in a second cell type, SYF cells, for which Rsrc cells
served as control (Fig. 6). Since SYF and Rsrc cells have different
levels of tyrosine-phosphorylated cortactin, we performed IPs with
4F11, pTyr Ab and pY466 Ab. As in WT and HDAC6 deficient
MEFs, endogenous tyrosine-phosphorylated cortactin was not
acetylated.
A major conclusion of our work is that phosphorylation of
cortactin has important repercussions on cell spreading, extending
the insights of a previous study showing that cortactin mutants
mimicking tyrosine phosphorylation affect focal adhesion turnover
[28]. Using the FIT system to control tyrosine phosphorylation of
cortactin, we analyzed the effect of phosphorylating cortactin on
cell location (Fig. S5) and cell spreading (Fig. 7). We found that
phosphorylated and unphosphorylated cortactin expressed
through transient transfection has an intracellular distribution
similar to that of endogenous protein [12]. More importantly,
phosphorylation affects cell spreading: cortactin expression
facilitated cell adhesion, while tyrosine phosphorylation inhibited
it. This phenotype was more noticeable in Rsrc cells, which
express Src, than in SYF cells, which do not contain the major
SFKs expressed in fibroblasts (Src, Yes and Fyn). This difference
between the cell lines is understandable given that many proteins
besides cortactin participate in cell adhesion, and many of them
are regulated by Src-mediated phosphorylation [43].
In an effort to understand the molecular mechanism underlying
the inhibitory effect of tyrosine phosphorylated cortactin on cell
spreading, we hypothesized that this post-translational modifica-
tion would affect the binding of cortactin SH3 domain to
interacting proteins that function in cell spreading. One obvious
candidate was FAK [37]. Our results in the present study
demonstrate that in vivo, as previously proposed in vitro [10],
tyrosine phosphorylation of cortactin prevents the SH3 domain
from interacting with FAK and potentially other proteins as well.
While we were preparing this manuscript for submission,
researchers reported that a tyrosine phosphorylation-mimicking
mutant of cortactin no longer binds FAK and promotes cell
motility [44]. This result is comparable to our results obtained with
cortactin mutants and with the endogenous protein after
Figure 8. Tyrosine phosphorylation of cortactin affects focal adhesion formation: staining for vinculin. SYF and Rsrc cells were
transfected with empty vectors, with ZipB-MycCortactin and empty vector (TF2) or with ZipB-MycCortactin and ZipA-HADSrc (TF3). Cells were fixed
and visualized by immunofluorescence using vinculin MoAb (in green) and myc Ab (in red). Photographs were taken using a Nikon Eclipse TE 200-U
fluorescence microscope equipped with a Hamamatsu camera. Images were processed with Adobe Photoshop. A scale bar is shown.
doi:10.1371/journal.pone.0033662.g008
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forms of cortactin but the phosphorylated form of the WT protein
to demonstrate directly that phosphorylation inhibits cortactin
binding to FAK and cell spreading. Our results point to a
significant role for tyrosine phosphorylation of cortactin in
regulating cell adhesion to fibronectin. This further suggests the
possibility that cortactin and its phosphorylation contribute to
integrin signaling.
Model
We propose a model for the ‘sequential’ activation of cortactin
(Fig. 10). The major tyrosines targeted by Src are located in the
proline-rich region at the C-terminus of the protein. Cortactin has
a closed, globular conformation, achieved mainly through
interactions among the SH3 domain, the ABR and helical region
[27]. This agrees with previous studies showing that in unmodified
cortactin, the SH3 domain is masked [10,22]. Since acetylated
cortactin has also been proposed to be inactive [30], we
hypothesize that acetylated cortactin has a closed conformation
as well.
Based on our observation that acetylation and tyrosine
phosphorylation are not present simultaneously, we propose that
in acetylated cortactin, the tyrosines targeted by Src are hidden.
Analysis of the tertiary structure of cortactin suggests that both
acetyl and phosphate groups can be close to each other in space
[45], which may explain why one process excludes the other.
Acetylation of the e-amino group of lysines has already been
suggested to ‘‘rival’’ phosphorylation in some cases [46]. Some
examples of phosphorylation-acetylation switches in the regulation
of proteins are already known. For example, Signal Transducers
and Activators of Transcription 1 (STAT1) is activated by
phosphorylation and inactivated by acetylation [47]. We further
propose that upon appropriate stimulation, such as focal adhesion
formation during cell spreading, cortactin is deacetylated, mainly
by HDAC6, which like cortactin can translocate to the cell
periphery [48]. This deacetylated status would be maintained by
rapid Src-mediated tyrosine phosphorylation, although we cannot
exclude the possibility that other post-translational modifications
contribute to inhibiting reacetylation. In essence, we propose that
tyrosine-phosphorylated cortactin is a ‘pre-activation state’. At the
present moment we do not know whether this species has an open
or closed configuration; this will require high-resolution structural
analysis.
Figure 9. Tyrosine phosphorylation of cortactin terminates its interaction with focal adhesion kinase (FAK) during cell spreading.
(A) Coomassie staining of purified GST and GST-cortactin SH3 domain was scanned in the Odyssey system. (B) HeLa cells were detached with trypsin-
EDTA, washed with trypsin inhibitor and kept in suspension (susp.) or allowed to spread for 3 h on fibronectin (FN)-treated 100-mm plates. RIPA cell
lysates were used for pull-down experiments with GST or GST-SH3, which were analyzed by SDS-PAGE and WB with focal adhesion kinase (FAK) Ab,
followed by labeling with a 800CW-conjugated goat rabbit Ab. (C) HeLa cells were transfected with ZipB-MycCortactin and empty vector (TF2) or with
ZipB-MycCortactin and ZipA-HADSrc (TF3). After 20 h cells were detached with trypsin-EDTA, washed with trypsin inhibitor and allowed to spread on
FN-coated 100-mm plates for 3 h. Cell lysates were subjected to immunoprecipitation with FAK MoAb. The immunoprecipitates were subjected to
WB and probed in three steps: (1) with myc Ab to detect transfected cortactin, followed by a 680CW-labeled goat mouseAb (red); (2) with FAK Ab,
followed by a 800CW-labeled goat rabbit Ab (green); and (3) with pY466 cortactin Ab, followed by a 800CW-labeled goat rabbit Ab. Transfected
cortactin was immunoprecipitated by FAK (asterisk) only when the protein was not tyrosine-phosphorylated.
doi:10.1371/journal.pone.0033662.g009
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Figure S1 Western-blotting controls for the transfec-
tions of the FIT vectors. (A) To detect our transfected protein,
lysates were analyzed by WB with a rabbit cortactin MoAb and a
mouse myc MoAb. Both MoAbs recognize transfected cortactin.
(B) Transfection and cell phenotype controls were performed by
WB with HA Ab (in green), and myc and Src MoAbs (in red).
(TIF)
Figure S2 Specificity of the FIT system as detected with
phosphotyrosine generic antibodies. SYF and Rsrc cells
were transfected with different combinations of Src and cortactin
FIT fusion vectors (lanes 1–8) or left untransfected (lane 9). The
cell lysates were blotted for actin as a loading control, and with a
mixture of two generic phosphotyrosine MoAbs: 4G10 and PY20
(Platinum). The major tyrosine-phosphorylated band observed in
our lysates corresponded to cortactin detected with rabbit
cortactin MoAb (in red) in the lysates cotransfected with ZipA-
HA-DSrc and ZipB-MycCortactin (lane 5, asterisks).
(TIF)
Figure S3 Analysis of acetylation and tyrosine phos-
phorylation of transfected cortactin. (A) Lysates from
various transfection combinations (lanes 1–4), treated or not with
the deacetylase inhibitor Trichostatin A (TSA), were blotted using
pY466 cortactin Ab (pY466) (in green) and 4F11 MoAb (in red) to
analyze the phosphorylation of transfected cortactin. (B) TSA-
treated cell lysates from various transfection combinations (lanes
1–3) were subjected to IP experiments with the pY466 Ab or
isotype control Ab (Ctrl.). The IPs were blotted first with acetyl-
cortactin Ab, and second with the cortactin 4F11 MoAb; then the
membrane was stripped and reprobed with pY466 Ab and with
cortactin 4F11 MoAb. The asterisk denotes nonspecific bands.
(TIF)
Figure S4 Analysis of acetylation and tyrosine phos-
phorylation of endogenous cortactin in WT and HDAC6-
deficient MEFs. Immunoprecipitates obtained with acetyl-
cortactin Ab were blotted with phospho-tyrosine generic mouse
MoAb (pTyr) and cortactin rabbit MoAb. There was not
phosphorylation signal to coincide with acetylated cortactin.
(TIF)
Figure S5 Localization of tyrosine-phosphorylated cor-
tactin. SYF and Rsrc cells were transfected with empty vectors
(not shown), with ZipB-MycCortactin and empty vector (TF2) or
with ZipB-MycCortactin and ZipA-HADSrc (TF3). Cells were
fixed and visualized by immunofluorescence using myc MoAb (in
blue), pY466 cortactin Ab (in green) and TRITC-phalloidin to
label actin cytoskeleton (in red). Pictures were taken on a confocal
microscope at 6006 magnification. Images were merged and a
zoomed view was generated using Leica software. Scale bars are
shown. Some cells showed clusters of actin and phospho-cortactin
(arrows).
(TIF)
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